Altogether, these studies link redox states with polymerisation and intracellular retention of AAT, suggesting that redox state is a modifier factor for AATD and that targeting OS may be a promising therapeutic option for these patients [101, 102]. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.